IBM Gets PTAB To Review Rival's Malware IP In $100M Row
The Patent Trial and Appeal Board has agreed to institute IBM's petition for inter partes review of a competitor's malware patent at the heart of a California infringement suit, declining Trusted...To view the full article, register now.
Already a subscriber? Click here to view full article